Inhibition of NADPH: Quinone Oxidoreductase Activity of Camel Lens ζ-Crystallin by Colchicine

ISSN: 1875-6662 (Online)
ISSN: 1573-4080 (Print)

Volume 13, 3 Issues, 2017

Download PDF Flyer

Current Enzyme Inhibition

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Professor Claudiu T. Supuran
University of Florence, Neurofarba Department
Sesto Fiorentino (Firenze)

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Inhibition of NADPH: Quinone Oxidoreductase Activity of Camel Lens ζ-Crystallin by Colchicine

Current Enzyme Inhibition, 10(2): 137-142.

Author(s): Ibrahim A. Alharbi, Majid Khan, Nayyar Rabbani, Abdulrahman M. Al-Senaidy, Mohammad A. Ismael and Mohammed A Ayoub.

Affiliation: Biochemistry Department - College of Science, King Saud University, P.O. Box 2455 – 11451 Riyadh, Kingdom of Saudi Arabia.


Colchicine is a toxic alkaloid known for its therapeutic applications. In addition to the inhibition of microtubule polymerization, colchicine has been reported to inhibit many key enzymes. Here we provide evidence for colchicine binding and inhibiting ζ-crystallin purified from camel eye lens. Indeed, we demonstrated the molecular interaction between colchicine and ζ-crystallin using fluorescence quenching. Moreover, colchicines inhibited ζ-crystallin activity with respect to two different substrates 9,10-phenanthrenequinone (PQ) and 1,2-Naphthoquinone (NQ) as well as NADPH as coenzyme. The inhibition was time-independent but concentration-dependent with an IC50 value of 1.52 ± 0.055 μM. NADPH was able to protect 38% of enzyme activity against colchicine whereas ζ-crystallin substrates protected only 12-16%. Kinetic analysis revealed that colchicine-induced inhibition of ζ-crystallin activity was non-competitive and uncompetitive with respect to PQ/NQ and NADPH, respectively. In addition, the kinetic analyses along with the protection assay clearly suggest that the binding of colchicine to ζ-crystallin occurs at or close to NADPH binding site. Our data reveal for the first time the inhibitory effect of colchicine on the oxidoreductase activity of camel lens ζ-crystallin illustrating the diversity of colchicine-targeted enzymes. Finally, our findings are of great importance in therapy since ζ-crystallin is known to play a key role in the detoxification processes. Therefore, a particular attention should be taken during colchicine-based therapies to avoid kidney injury and cataract formation.


ζ-crystallin, colchicine, NADPH, oxidoreductase, quinone.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 10
Issue Number: 2
First Page: 137
Last Page: 142
Page Count: 6
DOI: 10.2174/1573408010666140501171616
Price: $58
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017

Related Journals

Related eBooks

Webmaster Contact: Copyright © 2017 Bentham Science